Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emisphere's Eligen technology improves vitamin B12 absorption

This article was originally published in Scrip

Executive Summary

Use ofEmisphere Technologies' Eligen formulation process has improved the oral bioavailability of vitamin B12, the company has reported. An Eligen B12 product could circumvent the use of multiple injections or oral megadoses in those patients requiring vitamin B12 supplementation, Emisphere adds.

Advertisement
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC031142

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel